Sanguine Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 92
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 18

Sanguine General Information

Description

Developer of a platform designed to connect patients, mobile health providers, and researchers in a seamless workflow. The company provides tools and concierge services that empower patients to participate in research from home and connect patients with promising opportunities to advance breakthrough research, enabling researchers to investigate any therapeutic area.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Primary Office
  • 5000 Van Nuys Boulevard
  • Suite 205
  • Sherman Oaks, CA 91423
  • United States
+1 (855) 000-0000

Sanguine Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanguine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - PPP 08-Apr-2020 00.000 Completed Generating Revenue
5. Grant 01-Feb-2019 00000 00.000 Completed Generating Revenue
4. Accelerator/Incubator 18-Mar-2018 00.000 Completed Generating Revenue
3. Convertible Debt 01-Jul-2016 00000 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 29-May-2015 $5.53M $7.03M 000.00 Completed Startup
1. Seed Round 21-Feb-2013 $1.5M $1.5M 00.00 Completed Startup
To view Sanguine’s complete valuation and funding history, request access »

Sanguine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Sanguine’s complete cap table history, request access »

Sanguine Executive Team (8)

Name Title Board Seat Contact Info
Brian Neman Co-Founder, Chief Executive Officer & Board Member
Gerald Lee Chief Product Officer
You’re viewing 2 of 8 executive team members. Get the full list »

Sanguine Board Members (7)

Name Representing Role Since
Benjamin Weiss Heliant Ventures Board Member 000 0000
Brian Neman Sanguine Co-Founder, Chief Executive Officer & Board Member 000 0000
Donald Jones JD Self Board Member 000 0000
James Mervis JD Self Board Member 000 0000
Marvin Yee Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Sanguine Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sanguine Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government Minority 000 0000 000000 0
StartUp Health Venture Capital Minority 000 0000 000000 0
Albany Capital Real Estate Minority 000 0000 000000 0
AngelList Venture Capital Minority 000 0000 000000 0
Cody Cagnina Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »